Halia Therapeutics to Join the 6th Annual Needham Biotech and MedTech Forum #United_States #Biopharmaceutical #Lehi,_Utah #Halia_Therapeutics #Inflammasome

Vps4B controls caspase-1 dynamics at the ASC speck to drive #inflammasome activation. New study from Yanfeng Li, Qingqing Xie, Longjun Li, Xiaoqing Xu, Tao Xu, Xiaopeng Qi (Shandong University) and colleagues:
rupress.org/jem/article/...

#InfectiousDisease #HostDefense #InnateImmunity #inflammation

New @jem.org study by Li et al. identifies that the ATPase Vps4B controls caspase-1 dynamics at the ASC speck to promote #inflammasome activation. This self-rejuvenating mechanism of the ASC speck opens up new avenues for therapeutic intervention in inflammatory diseases. rupress.org/jem/article/...

New study by Li et al. identifies that the ATPase Vps4B controls caspase-1 dynamics at the ASC speck to promote #inflammasome activation. This self-rejuvenating mechanism of the ASC speck opens up new avenues for therapeutic intervention in inflammatory diseases. rupress.org/jem/article/...

Halia Therapeutics Set to Showcase Innovations at Morgan Stanley Healthcare Conference #USA #New_York #Halia_Therapeutics #Ofirnoflast #Inflammasome

Specific or feasible? Right now, #inflammasome biomarkers struggle to be both — and that’s a bottleneck for inflammasome inhibitors in the clinic. New review by Jared Coombs, @s-burgener.bsky.social and myself in J Mol Biol: authors.elsevier.com/a/1nUeG54HFd...